ATE34173T1 - Thiazolderivate als h2-rezeptor-antagonisten. - Google Patents

Thiazolderivate als h2-rezeptor-antagonisten.

Info

Publication number
ATE34173T1
ATE34173T1 AT82306785T AT82306785T ATE34173T1 AT E34173 T1 ATE34173 T1 AT E34173T1 AT 82306785 T AT82306785 T AT 82306785T AT 82306785 T AT82306785 T AT 82306785T AT E34173 T1 ATE34173 T1 AT E34173T1
Authority
AT
Austria
Prior art keywords
alkyl
halo
alkylene
alkoxy
optionally substituted
Prior art date
Application number
AT82306785T
Other languages
English (en)
Inventor
Richard Paul Pioch
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE34173T1 publication Critical patent/ATE34173T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Liquid Crystal Substances (AREA)
AT82306785T 1981-12-28 1982-12-20 Thiazolderivate als h2-rezeptor-antagonisten. ATE34173T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33478481A 1981-12-28 1981-12-28
EP82306785A EP0083186B1 (de) 1981-12-28 1982-12-20 Thiazolderivate als H2-Rezeptor-Antagonisten

Publications (1)

Publication Number Publication Date
ATE34173T1 true ATE34173T1 (de) 1988-05-15

Family

ID=23308823

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82306785T ATE34173T1 (de) 1981-12-28 1982-12-20 Thiazolderivate als h2-rezeptor-antagonisten.

Country Status (23)

Country Link
EP (1) EP0083186B1 (de)
JP (1) JPS58118585A (de)
KR (1) KR860000106B1 (de)
AT (1) ATE34173T1 (de)
AU (1) AU558153B2 (de)
CA (1) CA1206151A (de)
CS (1) CS235976B2 (de)
DD (1) DD203720A5 (de)
DE (1) DE3278473D1 (de)
DK (1) DK574782A (de)
ES (1) ES8403895A1 (de)
FI (1) FI824407L (de)
GB (1) GB2111995B (de)
GR (1) GR78415B (de)
HU (1) HU192951B (de)
IE (1) IE54313B1 (de)
IL (1) IL67496A (de)
NZ (1) NZ202797A (de)
PH (1) PH19797A (de)
PL (1) PL239796A1 (de)
PT (1) PT76004B (de)
SU (1) SU1195906A3 (de)
ZA (1) ZA829247B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468399A (en) * 1981-12-28 1984-08-28 Eli Lilly And Company 2-[2-(2-Aminoalkyl-4-thiazolylmethylthio)alkyl]-amino-5-substituted-4-pyrimidones
GB8320505D0 (en) * 1983-07-29 1983-09-01 Smith Kline French Lab Chemical compounds
US4772704A (en) * 1983-09-21 1988-09-20 Bristol-Myers Company 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
TW245716B (de) * 1992-12-28 1995-04-21 Takeda Pharm Industry Co
RU2250767C1 (ru) * 2004-07-12 2005-04-27 Казанский государственный медицинский университет Способ лечения язвенной болезни желудка и двенадцатиперстной кишки
CN102260254A (zh) * 2010-05-31 2011-11-30 中国农业科学院植物保护研究所 新颖2-硝基亚氨基嘧啶衍生物的合成

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
IN146736B (de) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
AU531142B2 (en) * 1979-04-04 1983-08-11 Smith Kline & French Laboratories Limited 2 amino- pyimindones
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Also Published As

Publication number Publication date
EP0083186B1 (de) 1988-05-11
EP0083186A3 (en) 1984-05-23
KR840002831A (ko) 1984-07-21
FI824407A7 (fi) 1983-06-29
JPS58118585A (ja) 1983-07-14
IE823031L (en) 1983-06-28
PT76004A (en) 1983-01-01
PL239796A1 (en) 1984-05-21
GR78415B (de) 1984-09-27
IL67496A (en) 1986-11-30
EP0083186A2 (de) 1983-07-06
IE54313B1 (en) 1989-08-16
ZA829247B (en) 1984-07-25
DD203720A5 (de) 1983-11-02
PT76004B (en) 1985-12-03
CS235976B2 (en) 1985-05-15
KR860000106B1 (ko) 1986-02-19
AU9153982A (en) 1983-07-07
PH19797A (en) 1986-07-02
GB2111995A (en) 1983-07-13
GB2111995B (en) 1985-07-24
FI824407L (fi) 1983-06-29
HU192951B (en) 1987-08-28
CA1206151A (en) 1986-06-17
NZ202797A (en) 1985-08-30
SU1195906A3 (ru) 1985-11-30
DK574782A (da) 1983-06-29
ES518592A0 (es) 1984-04-01
DE3278473D1 (en) 1988-06-16
AU558153B2 (en) 1987-01-22
FI824407A0 (fi) 1982-12-21
ES8403895A1 (es) 1984-04-01

Similar Documents

Publication Publication Date Title
SE8101409L (sv) Karbostyrilderivat och forfarande for framstellning derav
DE69133299D1 (de) Aminosulfonylcarbamate
ATE31307T1 (de) Benzofuran- und benzopyrancarboxamid-derivate.
FI823923L (fi) Antifibrinolytiskt aktiva foereningar
SE8104783L (sv) Heterocykliska foreningar
FI860369A0 (fi) Imidazolderivat, deras framstaellning och anvaendning samt dessa derivat innehaollande farmaceutiska kompositioner.
TW240227B (de)
AR247744A1 (es) Compuestos organosilano y catalizadores que contienen dichos compuestos
FI923774A0 (fi) 1,7-anellerande 2-(piperazinoalkyl) indolderivat samt foerfaranden och mellanprodukter foer deras framstaellning.
FI834730A0 (fi) 1-karboxialkanoylperhydro-indol-2-karboxylsyror och deras derivat
ES2068413T3 (es) Derivados de 4-fenilftalazina.
AU558153B2 (en) Pyrimidine derivatives of 1,3-thiazole
ES8801619A1 (es) Procedimiento para la obtencion de n-6-metoxi-5(perfluoroal-quil)-1-naftoil-n-metilglicinas y sus analogos tionaftoili- cos
DK221490D0 (da) Beta-carbonyl-carboxyamider af 1,3-thiazolidiner
DK199388D0 (da) Sulfonyldecahydro-8h-isoquino-oe2,1-gaaoe1,6aa-naphthyridiner, optiske isomerer deraf og beslaegtede forbindelser
FI914525A0 (fi) Foerening, anvaendning och framstaellning.
AR247737A1 (es) Un procedimiento para la fabricacion de compuestos.
ATE7786T1 (de) Verwendung von wachstumsregulierenden alphaazolylglykolen.
ES2062568T3 (es) Nuevos derivados de benzo (b) fenantrolinas-1,7 su preparacion y su aplicacion en terapeutica.
JPS56131571A (en) Novel hetero ring substituted carboxyamide and methyl amine compound
ES8707204A1 (es) Procedimiento para preparar diazepinoindoles
SE8103598L (sv) Antiinflammatoriska medel for yttre anvendning
TW360651B (en) Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesics and intermediates for their preparation
JPS52131589A (en) Trimethoxybenzylpiperazinoethanol derivatives